Edgar Haug is a founding partner of Frommer Lawrence & Haug LLP and its Managing Partner since 2003.
Mr. Haug has been engaged in litigation and counseling involving diverse aspects of intellectual property and competition law for many of the world’s leading companies. He litigates in complex technical fields, including pharmaceuticals and biotechnology, semi-conductors and associated manufacturing equipment, shape memory alloys, e-commerce, automotive designs and consumer electronics. He also counsels clients regularly in due diligence investigations.
Mr. Haug is nationally recognized as a trial lawyer and consultant specializing in pharmaceutical patent litigation under the Hatch-Waxman Amendments to the Federal Food, Drug & Cosmetic Act. He has represented clients involved in patent enforcement as well as regulatory and patent challenges involving many of the world's largest selling pharmaceuticals including Zantac, Paxil, Prozac, Omeprazole, Megace, Adderall XR, Neurontin, EPO, Trovax, Oxytrol, Carbatrol, and Duoneb.
Mr. Haug has substantial experience in both bench and jury trials as well as appellate practice. He has also been involved in proceedings before foreign jurisdictions including, the UK High Court, the German Federal Supreme Court, and the Tokyo High Court.
Mr. Haug has been a regular faculty member of the Practising Law Institute teaching all aspects of trial advocacy in patent cases. He is also a frequent lecturer for many professional organizations and has been a keynote speaker for the Bear Stearns HealthCare conferences in New York, London, Paris, and Zurich. He recently was appointed to the Board of Directors of the Federal Circuit Bar Association.
Edgar Haug has been listed in the New York Super Lawyers 2008 through 2010 Metro Editions.
PUBLICATIONS
- Edgar H. Haug, Discovery and Related Motion Practice, Winning Strategies in Patent Litigation, 1995 (PLI, Course Handbook Series 1995 - Volume One).
- Edgar H. Haug & Steven B. Pokotilow, Considerations in Crafting An Opening Statement, in Patent Litigation, 1996 (PLI, Course Handbook Series 1996 - Volume One).
- Edgar H. Haug & Steven B. Pokotilow, Opening Statements - Demonstrations and Panel Critique, in Patent Litigation, 1997 (PLI, Course Handbook Series 1997 - Volume One).
- Edgar H. Haug, Markman and the Use of Demonstrative Exhibits, in How to Prepare & Conduct Markman Hearings, 2001 (PLI, Course Handbook Series 2001).
- Edgar H. Haug, Roger W. Parkhurst & William C. Conner, Demonstration of a Direct and Cross-Examination of a Technical Expert Contending for Obviousness, in Patent Litigation 2004 (PLI, Course Handbook Series 2004).
- Edgar H. Haug, Claim Construction and Phillips -- The ‘Ordinary and Customary Meaning’, in How to Prepare & Conduct Markman Hearings 2006 (PLI, Course Handbook Series 2006).
- Beyond a Reasonable Doubt (2006)
SPEAKING ENGAGEMENTS
- Breaking Down Organizational and Cultural Barriers, LES/AUTM 2006 Spring Meeting, Philadelphia, Pennsylvania, May 10, 2006
- Regulatory Agencies and Federal Circuit Decision-Making, Federal Circuit Bar Association 8th Annual Bench and Bar Conference, Santa Ana Pueblo, New Mexico, June 2006
- Program: Trilateral Perspective on Patent Protection, Enforcement & Competition Law, Imperial Hotel, Tokyo, Japan, Sept. 28, 2006
- The Impact of IP on Corporate Transactions Law Seminars International's Conference, Dec. 6, 2006
- Industry Trends in Controlled Released Pharmaceutical Dosage Form Development, Glatt Pharmaceutical Services, Ramsey, New Jersey, September 19, 2007
- Bear Stearns Annual Health Care Convention, London, England, March 11, 2008
- Intellectual Property Seminar, Qingdao, China, April 24-25, 2008
- Procedural Differences in Europe and the US, IQPC's 4th Annual Conference on Polymorphism, Frankfurt, Germany, May 28, 2008
- Intellectual Property,” U.S.-Japan Business Council Annual Meeting. Tokyo, Japan, October 6, 2008
- The Global Courtroom,” IP Law Review Conference. Westin Hotel, New York City, October 29, 2008